An update on clinical practice of fecal microbiota transplantation

Yubo Ma,Tingyu Li,Haichao Cao,Kaichun Wu,Daiming Fan,Yongzhan Nie

DOI: https://doi.org/10.3877/cma.j.issn.2095-2015.2016.01.008

2016-01-01

Abstract:Human gastrointestinal(GI)tract contains at least 1014 bacteria,which can be categorized into more than 1 000 different species .Dysbiosis of intestinal flora is closely associated with many GI disorders and other extraintestinal conditions .There has been increasing interest in the application of fecal microbiota transplantation ( FMT)-the administration of fecal solution from a healthy donor into the intestinal tract of a patient-in order to change gut microbial dysbiosis and help to build microbiota with normal function . To date,FMT has been shown to be safe and effective with resolution of clostridium difficile infection .There has been a growing numbers of FMT-based intervention studies to investigate whether this technique can benefit other GI and extraintestinal disorders associated with gut microbial dysbiosis .Despite this increased attention,outcomes from different studies are quite inconsistent .Moreover, further studies are required to standardize procedures ,assess the safety and understand the mechanisms of this therapy .In this review,we explore and analyze the relationships between the role of gut microbiota and human health , detailed procedures and therapeutic potentials of FMT and provide reference for its further clinical application .